下村分枝杆菌空洞性肺病，预后良好。
Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
作者信息
Popovic Vide, Arar Dragan, Popovic Dragica Roso, Barisic Igor, Tonkic Marija, Peric Irena, Novak Anita, Rubic Zana, Katalinic-Jankovic Vera, Makek Mateja Jankovic, Goic-Barisic Ivana
机构信息
Clinic for Respiratory Disease, University Hospital of Split, Split, Croatia.
Clinic for Internal Medicine, University Hospital of Split, Split, Croatia.
出版信息
Folia Microbiol (Praha). 2018 Mar;63(2):249-252. doi: 10.1007/s12223-017-0548-1. Epub 2017 Sep 14.
We report a case of cavitary pulmonary disease caused by Mycobacterium shimoidei in 67-year-old female with history of asthma. Even though susceptibility testing was not available, choice of treatment regimen (streptomycin, rifampicin, ethambutol, and clarithromycin), based on a few cases with favorable outcome reported in the literature, resulted with an excellent clinical, microbiological, and radiological response. This is the first report of pulmonary disease caused by M. shimoidei, but also the first ever isolation of M. shimoidei in Croatia.
我们报告了一例由志摩分枝杆菌引起的空洞性肺部疾病，患者为一名67岁有哮喘病史的女性。尽管当时无法进行药敏试验，但根据文献中报道的少数几例预后良好的病例，选择的治疗方案（链霉素、利福平、乙胺丁醇和克拉霉素）取得了出色的临床、微生物学和影像学疗效。这是首例关于志摩分枝杆菌引起肺部疾病的报告，也是克罗地亚首次分离出志摩分枝杆菌。
Zotero 插件